Evergen
Kate Ryland is a skilled research and development professional with a background in biomaterials and biomedical engineering. Currently serving as a Research and Development Intern at RTI Surgical® since June 2023, Kate has contributed to the advancement of demineralized bone matrix allografts, conducting essential assays and leading feasibility studies while ensuring FDA regulatory compliance. Previous experience includes roles as a Clinical Trials Research Assistant at the Norman Fixel Institute for Neurological Diseases, a Biomaterials Research Co-Op at Arthrex, an Undergraduate Research Assistant at the University of Florida, a Product Development Intern at Amend Surgical, Inc., and a Pediatric Pulmonology Student Assistant at Shands at the University of Florida. Kate holds a Bachelor of Science in Materials Science and Engineering with a focus on Biomaterials from the University of Florida and is currently pursuing a Master of Science in Biomedical Engineering at the same institution.
This person is not in any offices
Evergen
4 followers
Evergen is a leading Contract Development and Manufacturing Organization (CDMO) pushing the boundaries of innovation and tissue engineering to meet patient needs in regenerative medicine. We are expert partners to Original Equipment Manufacturers (OEMs), working with them to identify clinical problems and develop customized solutions that promote healing, accelerate recovery, and help prevent complications. Using our extensive portfolio of biological materials, we focus on specialized clinical segments, including plastic and reconstructive surgery, sports medicine and orthopedics, cardiac, and neurosurgery.